Brazil lifts ban on controversial sterilization implants
What you need to know:
Sale of the implants, which was suspended in February, was authorized after its maker Bayer presented documents detailing test results that had been sought by the Brazilian Health Regulatory Agency (Anvisa).
These included results of clinical trials that lasted a year or longer as well as a report on measures taken by the maker after a warning by Canada's health agency.
